RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.9900
+0.0391 (4.11%)
At close: Feb 6, 2026, 4:00 PM EST
1.020
+0.030 (3.03%)
After-hours: Feb 6, 2026, 6:17 PM EST
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $36.28 million as of February 6, 2026. Its market cap has increased by 9.55% in one year.
Market Cap
36.28M
Enterprise Value
26.48M
1-Year Change
9.55%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $36.28M, a decrease of -47.14%. That is a compound annual growth rate of -13.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 36.28M | 17.84% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TuHURA Biosciences | 38.19M |
| Jasper Therapeutics | 37.78M |
| Veru Inc. | 37.56M |
| Celularity | 37.49M |
| Xilio Therapeutics | 36.53M |
| Generation Bio Co. | 36.04M |
| Actinium Pharmaceuticals | 35.88M |
| Atara Biotherapeutics | 35.19M |